Selective Targeting of Adjuvant Therapy for Endometrial Cancer: The STATEC Trial

这项针对患有侵袭性子宫内膜癌的妇女的国际合作试验将调查是否需要在子宫切除时切除淋巴结(淋巴清扫)，以预测患者是否需要额外的治疗，而不是不切除淋巴结并对所有此类患者进行额外的治疗。如果我们能够更准确地选择需要进一步治疗的患者，我们就可以避免给患者提供不必要的毒性治疗，从而影响他们的生活质量。

This international collaborative trial for women with aggressive endometrial cancer will investigate whether lymph node removal (lymphadenectomy) at time of hysterectomy is needed to predict whether patients need additional treatment, compared to not removing the lymph nodes and giving additional treatment to all such patients. If we can select patients who need further treatment more accurately, we will avoid giving patients unnecessary toxic treatment which impacts on their quality of life.